Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1155 CHF | +0.43% | -23.26% | +151.09% |
Apr. 24 | Top Premarket Decliners | MT |
Apr. 18 | Transcript : Addex Therapeutics Ltd, 2023 Earnings Call, Apr 18, 2024 |
Sales 2024 * | - | Sales 2025 * | 10.75M 11.75M | Capitalization | 14.81M 16.2M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.56M | Net income 2025 * | - 0 | EV / Sales 2024 * | - |
Net cash position 2024 * | 362K 396K | Net cash position 2025 * | 7.23M 7.9M | EV / Sales 2025 * | 0.71 x |
P/E ratio 2024 * |
-1.28
x | P/E ratio 2025 * |
2.1
x | Employees | 23 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.48% |
Latest transcript on Addex Therapeutics Ltd
1 day | +0.43% | ||
1 week | -23.26% | ||
Current month | +20.82% | ||
1 month | +21.84% | ||
3 months | +28.33% | ||
6 months | +119.58% | ||
Current year | +151.09% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Chairman | 75 | 09-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 54 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Chairman | 75 | 09-04-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.1155 | +0.43% | 1,832,556 |
24-04-25 | 0.115 | -6.50% | 364,591 |
24-04-24 | 0.123 | -9.23% | 1,407,251 |
24-04-23 | 0.1355 | -12.01% | 1,412,204 |
24-04-22 | 0.154 | +2.33% | 496,464 |
Delayed Quote Swiss Exchange, April 26, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+151.09% | 16.19M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ADXN Stock